Building a diagnostic prediction model for severe Mycoplasma pneumoniae pneumonia in children using machine learning
Chuxiong Gong1, Helang Yue2, Qinhong Li1
1Department of Cardiology, Kunming Children's Hospital, Kunming, Yunnan, China.
Objective:
Mycoplasma pneumoniae is the leading pathogen of community-acquired pneumonia in children. In recent years, M. pneumoniae pneumonia (MPP) has shown a global pandemic trend. The increasing incidence of severe MPP (SMPP) leads to complications and even deaths, severely impacting prognosis and quality of life. Our study aimed to use machine learning to construct an early diagnostic model for severe MPP in children. It supports early prediction, prevention, and individualized precise treatment of SMPP.
Methods:
We collected medical records from 372 MPP cases. We compared case characteristics between groups with and without SMPP and used a random forest to screen key factors. We then constructed a multivariate logistic prediction model. We evaluated the model with ROC curves, calibration curves, and DCA. Five-fold cross-validation tested prediction stability.
Results:
We identified ESR, PCT, IL-6, and lung auscultation as key factors to construct the prediction model. The model's ROC was 0.964 (95% CI: 0.945-0.983). Calibration curves and DCA confirmed model accuracy. Five-fold cross-validation validated internal stability.
Conclusion:
Our study developed a prediction model with good efficacy for early SMPP risk assessment. Our research provides a basis for clinical early prediction and prevention of SMPP, reducing its risk and offering a foundation for individualized treatment and improved long-term outcomes in affected children.
Insights
This study developed a machine learning model to predict severe Mycoplasma pneumoniae pneumonia (MPP) in children. Early detection using ESR, PCT, IL-6, and lung auscultation aids in timely intervention and better outcomes.
Area of Science:
- Pediatric infectious diseases
- Machine learning in healthcare
- Respiratory medicine
Background:
- Mycoplasma pneumoniae pneumonia (MPP) is a leading cause of community-acquired pneumonia in children.
- A global increase in MPP incidence, particularly severe cases (SMPP), necessitates improved diagnostic tools.
- Severe MPP significantly impacts prognosis, leading to complications and mortality.
Purpose of the Study:
- To develop and validate a machine learning-based early diagnostic model for severe MPP in children.
- To identify key clinical and laboratory factors predictive of SMPP.
- To support early prediction, prevention, and personalized treatment strategies for SMPP.
Main Methods:
- Retrospective analysis of 372 pediatric MPP cases.
- Utilized random forest for feature selection, identifying ESR, PCT, IL-6, and lung auscultation.
- Constructed a multivariate logistic prediction model and validated using ROC curves, calibration curves, decision curve analysis (DCA), and cross-validation.
Main Results:
- The developed prediction model demonstrated high accuracy with an ROC of 0.964.
- Key predictors identified include erythrocyte sedimentation rate (ESR), procalcitonin (PCT), interleukin-6 (IL-6), and lung auscultation findings.
- Model validation confirmed its accuracy and internal stability through calibration curves, DCA, and cross-validation.
Conclusions:
- A robust machine learning model for early SMPP risk assessment has been successfully developed.
- This model provides a valuable tool for clinicians to facilitate early diagnosis and prevention of SMPP.
- The findings lay the groundwork for individualized treatment approaches, aiming to improve long-term outcomes for children with severe MPP.
